The simplified reference tissue model for SPECT/PET brain receptor studies. Interpretation of its parameters
- PMID: 18690377
The simplified reference tissue model for SPECT/PET brain receptor studies. Interpretation of its parameters
Abstract
Aim: The SRTM (simplified reference tissue model) of brain receptor imaging assumes that the time activity curve in the receptor-rich region of interest can be fitted satisfactorily by the 1-tissue compartment model. This assumption has been formulated by a rather restrictive constraint on the rate constants. Empirically, the SRTM might well describe also tracers which do not fulfil this constraint, such as [(11)C]raclopride, for example. However, this has not been justified rigorously.
Methods: The requirements for the SRTM to be applicable are analyzed in detail.
Results: The SRTM is applicable under a less restrictive constraint than described previously. The interpretation of the SRTM parameters R(1) and k(2) in physiological terms depends on the constraint, while the interpretation of BP(ND) does not.
Conclusion: Correct interpretation of the results of the SRTM is tracer specific. In particular, the parameter R(1), which in case of compliance with the original constraint might be used to detect perfusion and/or extraction effects, might not be appropriate for this purpose in case of raclopride-like tracers.
Similar articles
-
Quantitative evaluation of changes in binding potential with a simplified reference tissue model and multiple injections of [11C]raclopride.Neuroimage. 2009 Oct 1;47(4):1639-48. doi: 10.1016/j.neuroimage.2009.05.099. Epub 2009 Jun 9. Neuroimage. 2009. PMID: 19520172
-
Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.J Nucl Med. 2006 Jun;47(6):919-28. J Nucl Med. 2006. PMID: 16741300 Clinical Trial.
-
Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters.Neuroimage. 2002 Oct;17(2):928-42. Neuroimage. 2002. PMID: 12377167 Clinical Trial.
-
Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.J Cereb Blood Flow Metab. 2000 Mar;20(3):423-51. doi: 10.1097/00004647-200003000-00001. J Cereb Blood Flow Metab. 2000. PMID: 10724107 Review.
-
Neuronuclear assessment of patients with epilepsy.Semin Nucl Med. 2008 Jul;38(4):227-39. doi: 10.1053/j.semnuclmed.2008.02.004. Semin Nucl Med. 2008. PMID: 18514079 Review.
Cited by
-
Dynamic multi-pinhole collimated brain SPECT of Parkinson's disease by [123I]FP-CIT: a feasibility study of fSPECT.Sci Rep. 2024 Mar 19;14(1):6624. doi: 10.1038/s41598-024-57152-5. Sci Rep. 2024. PMID: 38503852 Free PMC article.
-
Analysis of 5-HT(2A) receptor binding with [(11)C]MDL 100907 in rats: optimization of kinetic modeling.Mol Imaging Biol. 2013 Dec;15(6):730-8. doi: 10.1007/s11307-013-0633-z. Mol Imaging Biol. 2013. PMID: 23660769
-
The applicability of SRTM in [(18)F]fallypride PET investigations: impact of scan durations.J Cereb Blood Flow Metab. 2011 Sep;31(9):1958-66. doi: 10.1038/jcbfm.2011.73. Epub 2011 May 18. J Cereb Blood Flow Metab. 2011. PMID: 21587267 Free PMC article.
-
Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with ¹⁸F-dopa brain PET in normal controls and patients with Parkinson's disease.Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1550-9. doi: 10.1007/s00259-011-1819-8. Epub 2011 May 7. Eur J Nucl Med Mol Imaging. 2011. PMID: 21553090 Clinical Trial.